- Home
- CLDT vs PROK Comparison
CLDT vs PROK Comparison
Compare CLDT & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- PROK
- Stock Information
- Founded
- CLDT 2009
- PROK 2015
- Country
- CLDT United States
- PROK United States
- Employees
- CLDT N/A
- PROK N/A
- Industry
- CLDT Real Estate Investment Trusts
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLDT Real Estate
- PROK Health Care
- Exchange
- CLDT Nasdaq
- PROK Nasdaq
- Market Cap
- CLDT 374.7M
- PROK 417.1M
- IPO Year
- CLDT 2010
- PROK N/A
- Fundamental
- Price
- CLDT $6.35
- PROK $2.77
- Analyst Decision
- CLDT Strong Buy
- PROK Strong Buy
- Analyst Count
- CLDT 2
- PROK 4
- Target Price
- CLDT $10.75
- PROK $6.25
- AVG Volume (30 Days)
- CLDT 293.6K
- PROK 2.1M
- Earning Date
- CLDT 11-05-2025
- PROK 11-12-2025
- Dividend Yield
- CLDT 5.62%
- PROK N/A
- EPS Growth
- CLDT N/A
- PROK N/A
- EPS
- CLDT 0.03
- PROK N/A
- Revenue
- CLDT $310,140,000.00
- PROK $527,000.00
- Revenue This Year
- CLDT N/A
- PROK $471.74
- Revenue Next Year
- CLDT $0.52
- PROK N/A
- P/E Ratio
- CLDT $233.43
- PROK N/A
- Revenue Growth
- CLDT N/A
- PROK N/A
- 52 Week Low
- CLDT $5.83
- PROK $0.46
- 52 Week High
- CLDT $10.00
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- CLDT 41.00
- PROK 43.35
- Support Level
- CLDT $6.25
- PROK $2.71
- Resistance Level
- CLDT $6.49
- PROK $3.27
- Average True Range (ATR)
- CLDT 0.15
- PROK 0.21
- MACD
- CLDT 0.02
- PROK -0.06
- Stochastic Oscillator
- CLDT 46.15
- PROK 10.61
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.